- Macy's Loss Beats Estimates, But Shares Fall on Outlook
- AIG CEO Ready to Quit over Pay Constraints: Report
- Pay Caps Make it Hard for GM to Hire Execs: Whitacre
- Tresury Report Says $209 Billion Left in TARP Funds
- Unemployment May Cause Loan Defaults in US: Zoellick
- UPS Sees 2010 Volume Growth, Higher Rates
- Sen. Dodd: Fed Should Return To 'Core Functions'
- Just 1 in 20 Plan to Buy a Home Next Year: Survey
- Website Launches That Gives Free Access to Concerts
- Commercial Real Estate Best Place For Money: Strategist
- Schork Oil Outlook: Nat Gas Bulls Didn’t Stand A Chance
- Enterprise Tech Companies to Focus On: Portfolio Manager
- Agassi Book Buzz Paying Off Early
- Cadillac Converj Smart Extension of Volt
- This Chemical Company Will Rally into 2010: Trader
- 3 Safe Investments That Let You ‘Sleep Better:’ Strategist
- Beware of 'Trampling Effect' When Market Tops: Manager
- Gold Heading to $1150: Art Hogan
- Businesses fear Europe's recovery to remain timid
- Carnahan excited, concerned about health care bill
- Kan. education board laments cuts in school funds
- Denver man accused in $12.5 million Ponzi scheme
- PSE&G cleared for additional NJ solar projects
- DeVry increases annual dividend by 25 percent
- State's Oct. revenue collections below projections
- A123 3Q loss widens, revenue edges up
- RI expects nearly $200M deficit as economy dives
Panel likes blood thinner — for some patients
Text Size 
There’s life-saving potential, but don’t give to stroke patients, experts say
SILVER SPRING, Md. - A panel of government health experts says a highly anticipated Eli Lilly blood thinner has lifesaving potential, but should not be given to patients with a history of stroke.
Expert advisers to the Food and Drug Administration say the drug's labeling should alert doctors that stroke patients face a high risk of suffering another stroke if they take the medication.
The panel will vote later today on whether to recommend approval of the experimental drug. The FDA is not required to follow the group's recommendations, though it usually does.
Indianapolis-based Eli Lilly has asked the Food and Drug Administration to approve its highly anticipated drug to prevent dangerous blood clots in patients with acute heart problems.
Click for related content
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Print
Email
- Bernard and Ruth Madoff's personal possessions will be auctioned this weekend. Click ahead to see.
- If you are lucky enough to have money and the time, this is a great time to see America, says CNBC's Jane Wells.
- Vote and suggest your own, and remember--there's a fine line between a hero and a zero.
- How the Lord’s Prayer would read if Goldman Sachs’ Lloyd Blankfein were substituted for you-know-who.
- With 123 years of history, slogans and commercials, Coca-Cola is the most recognized brand on earth.
- The opening of a virtual pet store in “World of Warcraft” could prove a cash bonanza for Activision-Blizzard.
Data is a real-time snapshot *Data is delayed at least 15 minutes